They further demonstrated that miR-195 markedly decreases hepatoma cell migration and invasion by directly inhibiting the expression of the pro-angiogenic factor vascular endothelial growth factor (VEGF) and the pro-metastatic factors VAV2 and CDC42 [7]. This evidence concerns the gene VEGFA and hepatocellular carcinoma.